Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension

  Free Subscription


13.05.2024

1 ACS Omega
1 Acta Pharmacol Sin
1 Aging (Albany NY)
1 Am J Respir Cell Mol Biol
1 BMC Pulm Med
1 Cardiovasc Diabetol
3 Chest
1 Circ Res
1 Drug Discov Today
1 Eur J Pharmacol
1 Front Cardiovasc Med
1 Hypertens Res
2 Int J Cardiol
1 Int J Rheum Dis
1 J Affect Disord
1 J Am Heart Assoc
1 J Chemother
1 J Vet Intern Med
1 JACC Heart Fail
1 medRxiv
1 Nat Rev Drug Discov
1 Open Heart
1 Pediatr Emerg Care
1 PeerJ
1 Pulm Circ
2 Respir Res
1 Stem Cells
1 Zhonghua Jie He He Hu Xi Za Zhi


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Omega

  1. ALMUTAIRY BK, Khafagy ES, Aldawsari MF, Alshetaili A, et al
    Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension.
    ACS Omega. 2024;9:19536-19547.
    PubMed         Abstract available


    Acta Pharmacol Sin

  2. LI XC, Zhu XY, Wang YY, Tong SL, et al
    Canagliflozin alleviates pulmonary hypertension by activating PPARgamma and inhibiting its S225 phosphorylation.
    Acta Pharmacol Sin. 2024 May 8. doi: 10.1038/s41401-024-01286.
    PubMed         Abstract available


    Aging (Albany NY)

  3. ZHANG L, Gu X
    4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling.
    Aging (Albany NY). 2024;16.
    PubMed         Abstract available


    Am J Respir Cell Mol Biol

  4. ZHANG J, Dong F, Ju G, Pan X, et al
    Sodium Houttuyfonate Alleviates MCT-induced Pulmonary Hypertension by Regulating Orai1 and Orai2.
    Am J Respir Cell Mol Biol. 2024 May 6. doi: 10.1165/rcmb.2023-0015.
    PubMed         Abstract available


    BMC Pulm Med

  5. FREIDKIN L, Kramer MR, Rosengarten D, Izhakian S, et al
    The acute effect of inhaled nitric oxide on the exercise capacity of patients with advanced interstitial lung disease: a randomized controlled trial.
    BMC Pulm Med. 2024;24:226.
    PubMed         Abstract available


    Cardiovasc Diabetol

  6. ZHANG S, Gao L, Li S, Luo M, et al
    Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study.
    Cardiovasc Diabetol. 2024;23:154.
    PubMed         Abstract available


    Chest

  7. RICE JL, Austin ED, Mathai SC, Sahay S, et al
    Genetic Testing in Pulmonary Arterial Hypertension Evaluation: A Patient and Clinician Survey.
    Chest. 2024;165:1224-1227.
    PubMed        

  8. CHEN Y, Li J, Li F, Chen Z, et al
    Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension.
    Chest. 2024;165:1211-1223.
    PubMed         Abstract available

  9. GENECAND L, Lador F, Montani D, Perneger T, et al
    Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
    Chest. 2024;165:e161.
    PubMed        


    Circ Res

  10. ZAFEIROPOULOS S, Ahmed U, Bekiaridou A, Jayaprakash N, et al
    Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension.
    Circ Res. 2024 May 7. doi: 10.1161/CIRCRESAHA.123.323679.
    PubMed         Abstract available


    Drug Discov Today

  11. SHUFIAN ISHTIAQ AHMED A, Blood AB, Zhang L
    Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development.
    Drug Discov Today. 2024 May 6:104015. doi: 10.1016/j.drudis.2024.104015.
    PubMed         Abstract available


    Eur J Pharmacol

  12. YAMAMURA A, Fujiwara M, Kawade A, Amano T, et al
    Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Eur J Pharmacol. 2024;973:176564.
    PubMed         Abstract available


    Front Cardiovasc Med

  13. LIU Q, Zhao C, Dang P, Li Y, et al
    Prognostic value of pulmonary hypertension with a nomogram in acute myocardial infarction patients with reduced left ventricular function.
    Front Cardiovasc Med. 2024;11:1368139.
    PubMed         Abstract available


    Hypertens Res

  14. WANG Z, Zhang YX, Shi JZ, Yan Y, et al
    RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.
    Hypertens Res. 2024;47:1273-1287.
    PubMed         Abstract available


    Int J Cardiol

  15. MANZI G, Recchioni T, Badagliacca R, Papa S, et al
    Fixed-dose combination therapy in pulmonary arterial hypertension: Pros & cons.
    Int J Cardiol. 2024;406:132003.
    PubMed         Abstract available

  16. HIRAKAWA K, Asano R, Ueda J, Aoki T, et al
    Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
    Int J Cardiol. 2024;406:132043.
    PubMed         Abstract available


    Int J Rheum Dis

  17. SHREYAS R, Patteri A, Hayagrivas MB, Singla T, et al
    Fatal pulmonary arterial hypertension (PAH): A rare association of anti-MDA-5 positive juvenile dermatomyositis.
    Int J Rheum Dis. 2024;27:e15180.
    PubMed        


    J Affect Disord

  18. ZHANG Z, Kutty S, Peng W, Zeng G, et al
    Causal association of depression, anxiety, cognitive performance, the brain cortical structure with pulmonary arterial hypertension: A Mendelian randomization study.
    J Affect Disord. 2024;356:356-362.
    PubMed         Abstract available


    J Am Heart Assoc

  19. MALIK AA, Saraswati U, Miranda WR, Covington M, et al
    Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy.
    J Am Heart Assoc. 2024;13:e032520.
    PubMed         Abstract available


    J Chemother

  20. ACAR C, Sahin G, Yuksel HC, Karaca B, et al
    Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension.
    J Chemother. 2024 May 8:1-6. doi: 10.1080/1120009X.2024.2349858.
    PubMed         Abstract available


    J Vet Intern Med

  21. CORDA A, Corda F, Pentcheva P, Puci M, et al
    The echocardiographic pulmonary to left atrial ratio: A noninvasive variable for the hemodynamic classification of pulmonary hypertension in dogs.
    J Vet Intern Med. 2024 May 7. doi: 10.1111/jvim.17097.
    PubMed         Abstract available


    JACC Heart Fail

  22. RATWATTE S, Stewart S, Strange G, Playford D, et al
    Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction.
    JACC Heart Fail. 2024;12:936-945.
    PubMed         Abstract available


    medRxiv

  23. MA JI, Owunna N, Jiang NM, Huo X, et al
    Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction.
    medRxiv [Preprint]. 2024 Apr 27:2024.04.25.24306398.
    PubMed         Abstract available


    Nat Rev Drug Discov

  24. KINGWELL K
    FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept.
    Nat Rev Drug Discov. 2024;23:327.
    PubMed        


    Open Heart

  25. ORBAEK ANDERSEN M, Diederichsen SZ, Svendsen JH, Carlsen J, et al
    Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension.
    Open Heart. 2024;11:e002710.
    PubMed         Abstract available


    Pediatr Emerg Care

  26. ZHANG Y, Wen J, Zeng M, Zhang L, et al
    A Nomogram Prediction Model for Persistent Pulmonary Hypertension of the Newborn in Neonates Hospitalized for the First Time After Birth.
    Pediatr Emerg Care. 2024 May 9. doi: 10.1097/PEC.0000000000003167.
    PubMed         Abstract available


    PeerJ

  27. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
    Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    PeerJ. 2024;12:e17186.
    PubMed         Abstract available


    Pulm Circ

  28. MERRILL K, Davis A, Jackson E, Riker M, et al
    Direct prostacyclin transition in pediatric patients with pulmonary hypertension.
    Pulm Circ. 2024;14:e12373.
    PubMed         Abstract available


    Respir Res

  29. TANG B, Vadgama A, Redmann B, Hong J, et al
    Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics.
    Respir Res. 2024;25:192.
    PubMed         Abstract available

  30. WANG D, Huang S, Cao J, Feng Z, et al
    A comprehensive study on machine learning models combining with oversampling for bronchopulmonary dysplasia-associated pulmonary hypertension in very preterm infants.
    Respir Res. 2024;25:199.
    PubMed         Abstract available


    Stem Cells

  31. ZHANG Q, Liu H, Liu C, Wang Y, et al
    Tibetan Mesenchymal Stem Cell-derived Exosomes Alleviate Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Rats.
    Stem Cells. 2024 May 8:sxae032. doi: 10.1093.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi


  32. [Consensus on the procedure of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:404-418.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.